Profile
Full Name
GlycoMimetics, Inc.Ticker Symbol
GLYCExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
January 10, 2014Indexes
Not includedWebsite
http://www.glycomimetics.comEmployees
4Key Details
Price
$0.23(+4.55%)
Market cap
$14.84M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.59(-1.72% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
GlycoMimetics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 21, 25 Cantor Fitzgerald
OverweightJul 26, 24 TD Cowen
HoldJun 4, 24 HC Wainwright & Co.
NeutralMay 6, 24 HC Wainwright & Co.
NeutralMar 27, 24 HC Wainwright & Co.
BuyDec 22, 23 Capital One
OverweightAug 3, 23 HC Wainwright & Co.
BuyJun 15, 23 HC Wainwright & Co.
BuyMay 4, 23 HC Wainwright & Co.
BuyMar 30, 23 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for GlycoMimetics?
- Does GlycoMimetics pay dividends?
- What sector is GlycoMimetics in?
- What industry is GlycoMimetics in?
- What country is GlycoMimetics based in?
- When did GlycoMimetics go public?
- Is GlycoMimetics in the S&P 500?
- Is GlycoMimetics in the NASDAQ 100?
- Is GlycoMimetics in the Dow Jones?
- When was GlycoMimetics's last earnings report?
- When does GlycoMimetics report earnings?
- Should I buy GlycoMimetics stock now?
What is the ticker symbol for GlycoMimetics?
The ticker symbol for GlycoMimetics is NASDAQ:GLYC
Does GlycoMimetics pay dividends?
No, GlycoMimetics does not pay dividends
What sector is GlycoMimetics in?
GlycoMimetics is in the Healthcare sector
What industry is GlycoMimetics in?
GlycoMimetics is in the Biotechnology industry
What country is GlycoMimetics based in?
GlycoMimetics is headquartered in United States
When did GlycoMimetics go public?
GlycoMimetics's initial public offering (IPO) was on January 10, 2014
Is GlycoMimetics in the S&P 500?
No, GlycoMimetics is not included in the S&P 500 index
Is GlycoMimetics in the NASDAQ 100?
No, GlycoMimetics is not included in the NASDAQ 100 index
Is GlycoMimetics in the Dow Jones?
No, GlycoMimetics is not included in the Dow Jones index
When was GlycoMimetics's last earnings report?
GlycoMimetics's most recent earnings report was on Nov 13, 2024
When does GlycoMimetics report earnings?
The next expected earnings date for GlycoMimetics is May 9, 2025
Should I buy GlycoMimetics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions